AllerGen investigator, partner organization help launch epinephrine auto-injector pilot project in Hamilton

AllerGen investigator, partner organization help launch epinephrine auto-injector pilot project in Hamilton

ac2A pilot project, led by the City of Hamilton and involving McMaster University and AllerGen partner Anaphylaxis Canada, is being launched today (September 8, 2014) in Hamilton. The project will analyze the effects of stocking epinephrine auto-injectors at Jackson Square shopping mall, and of training mall security guards to recognize an anaphylactic reaction and to administer the auto-injectors. The analysis will be conducted by a research team headed by AllerGen investigator Dr. Susan Waserman.

For more information, read the press release here.